Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Medchemexpress LLC Gamitrinib TPP hexafluorophosphate | 1131626-47-5 | MFCD31715433 | 99.7% | 1,036.03 g/mol | C52H65F6N3O8P2 | 50 MG
Supplier: Medchemexpress LLC HY102007A50MG
Gamitrinib TPP hexafluorophosphate is a mitochondria-targeted HSP90 inhibitor used in preclinical research to selectively disrupt mitochondrial HSP90 function and impair tumor bioenergetics. The triphenylphosphonium (TPP) moiety directs the compound to the mitochondrial matrix, increasing mitochondrial accumulation and cytotoxic activity in cell and animal cancer models.
- Mitochondria-targeted HSP90 inhibitor
- Targets mitochondrial bioenergetics and induces cancer cell death
- Enhanced mitochondrial accumulation via triphenylphosphonium moiety
- Reported high chemical purity (≈99.7%)
- Provided as a solid for preclinical research use
Product Title
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.
Spot an opportunity for improvement?